Huntleigh Advisors, Inc. Cellebrite Di Ltd. Transaction History
Huntleigh Advisors, Inc.
- $518 Billion
- Q2 2025
A detailed history of Huntleigh Advisors, Inc. transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Huntleigh Advisors, Inc. holds 48,950 shares of CLBT stock, worth $911,449. This represents 0.15% of its overall portfolio holdings.
Number of Shares
48,950
Previous 47,129
3.86%
Holding current value
$911,449
Previous $916 Million
14.47%
% of portfolio
0.15%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding CLBT
# of Institutions
216Shares Held
99.2MCall Options Held
122KPut Options Held
80.8K-
True Wind Capital Management, L.P.13.9MShares$258 Million93.81% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.52MShares$121 Million0.07% of portfolio
-
Voss Capital, LLC Houston, TX5.15MShares$95.9 Million6.92% of portfolio
-
Morgan Stanley New York, NY4.65MShares$86.6 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.51MShares$65.3 Million0.01% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $3.53B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...